XML 45 R35.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share-Based Payments: (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Dec. 31, 2018
Sep. 30, 2022
Mar. 31, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Subsidiary or Equity Method Investee [Line Items]            
Share-based payment arrangement, expense   $ 470,000   $ 710,000 $ 2,350,000 $ 2,150,000
Decreased income   340,000   480,000 1,520,000 1,420,000
Weighted average remaining contractual life of options outstanding (in years)         2 years 1 month 13 days  
Weighted average remaining contractual life of options exercisable (in years)         1 year 9 months 3 days  
Aggregate intrinsic value of options outstanding and options exercisable   $ 7,800,000     $ 7,800,000  
Aggregate intrinsic value of options outstanding and options exercisable   5,900,000     5,900,000  
Unrecognized compensation cost   1,900,000     1,900,000  
Adjusted for stock splits 211,955          
Recognized as compensation cost $ 4,800,000 $ 3,200,000     $ 3,000,000  
Interparfums SA Subsidiary [Member] | Employees [Member]            
Subsidiary or Equity Method Investee [Line Items]            
Aggregate shares to offices and managers 26,600 63,281 88,400   63,281  
Number of share distributed         66,905  
Interparfums SA Subsidiary [Member] | Officers and Managers [Member]            
Subsidiary or Equity Method Investee [Line Items]            
Aggregate shares to offices and managers 133,000          
Equity Option [Member]            
Subsidiary or Equity Method Investee [Line Items]            
Fair value of shares vested         $ 110,000 $ 900,000
Equity Option [Member] | Minimum [Member]            
Subsidiary or Equity Method Investee [Line Items]            
Options vesting period     4 years      
Equity Option [Member] | Maximum [Member]            
Subsidiary or Equity Method Investee [Line Items]            
Options vesting period     5 years